Paul E Swanson
Overview
Explore the profile of Paul E Swanson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
3453
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez R, Horton R, Zhang X, Graham R, Longacre T, Mehrotra A, et al.
Histopathology
. 2025 Jan;
PMID: 39887413
Aims: We compiled two cohorts of colorectal adenosquamous carcinoma (ASC) to describe its histologic and molecular aspects using modern parameters to compare them with literature reports using meta-analysis of cohorts...
2.
Sholl L, Awad M, Roy U, Beasley M, Cartun R, Hwang D, et al.
Arch Pathol Lab Med
. 2024 Apr;
148(7):757-774.
PMID: 38625026
Context.—: Rapid advancements in the understanding and manipulation of tumor-immune interactions have led to the approval of immune therapies for patients with non-small cell lung cancer. Certain immune checkpoint inhibitor...
3.
Goldsmith J, Troxell M, Roy-Chowdhuri S, Colasacco C, Edgerton M, Fitzgibbons P, et al.
Arch Pathol Lab Med
. 2024 Feb;
148(6):e111-e153.
PMID: 38391878
Context.—: In 2014, the College of American Pathologists developed an evidence-based guideline to address analytic validation of immunohistochemical assays. Fourteen recommendations were offered. Per the National Academy of Medicine standards...
4.
Coveler A, Pillarisetty V, Koh W, Zhen D, Park J, King G, et al.
Pancreas
. 2023 Oct;
52(5):e282-e287.
PMID: 37782886
Objectives: Pancreatic ductal adenocarcinoma (PDA) is the third most common cause of cancer death in the United States. Most patients who undergo resection develop recurrence. Standard treatment confers a median...
5.
Pham L, Swanson P, Tomizawa Y
ACG Case Rep J
. 2023 Jan;
9(12):e00948.
PMID: 36628375
A 76-year-old woman was referred for 6 months of progressively worsening dysphagia and unintentional weight loss. An esophagogastroduodenoscopy demonstrated an area of extrinsic compression in the lower esophagus measuring 7...
6.
Hsu M, Ju J, Pearson M, Yu L, Swanson P, Yeh M
Am J Clin Pathol
. 2022 Sep;
158(6):770-773.
PMID: 36048887
Objectives: Primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH) can be difficult to distinguish in end-stage liver disease. Previous studies have shown that immunoglobulin G (IgG) and immunoglobulin M (IgM)...
7.
Reed A, Kohn M, Stayman S, Cole A, Ko C, Konnick E, et al.
Contemp Clin Trials
. 2022 Mar;
116:106735.
PMID: 35331945
Background: Diagnosis of Lynch and other hereditary colorectal cancer (CRC) syndromes through germline genetic testing has important implications for treatment and risk-management, yet guideline-recommended genetic counseling referral and attendance is...
8.
Bosch D, Swanson P, Yeh M
Histopathology
. 2021 Nov;
80(4):708-719.
PMID: 34843118
Aims: Centrizonal hepatocyte dropout has been described in diverse liver pathologies, including viral hepatitis, venous outflow obstruction, and allograft cellular rejection. However, its clinical significance remains uncertain. Methods And Results:...
9.
Bosch D, Salipante S, Schmidt R, Swanson P, Bryan A, SenGupta D, et al.
Ann Diagn Pathol
. 2021 Nov;
56:151845.
PMID: 34763224
Gallbladder carcinoma is an uncommon malignancy with an overall 5-year survival of less than 5%. Gallbladder carcinoma has been strongly linked with cholelithiasis and chronic inflammation. Case reports and series...
10.
Wu B, Liu Y, Rogers J, Liu Y, Rabinovitch P, Small T, et al.
Am J Clin Pathol
. 2021 Sep;
157(3):417-425.
PMID: 34542607
Objectives: Histopathologic evaluation of bile biopsies for biliary strictures is frequently challenging and is affected by interobserver disagreement. Reliable ancillary tests that can help differentiate benign from malignant are not...